Vident Investment Advisory’s Precision BioSciences DTIL Stock Holding History

Vident Investment Advisory’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-593	Closed	-$55K	–	1306
2022 Q1	$55K	Sell	593 -131	-18%	-$17.8K	﹤0.01%	1246
2021 Q4	$161K	Buy	+724	New	+$202K	﹤0.01%	1159
2021 Q3	–	Sell	-658	Closed	-$247K	–	1177
2021 Q2	$247K	Buy	+658	New	+$198K	0.01%	985
2020 Q2	–	Sell	-4,995	Closed	-$904K	–	853
2020 Q1	$904K	Sell	4,995 -312	-6%	-$81.7K	0.06%	425
2019 Q4	$2.21M	Buy	5,307 +1,537	+41%	+$483K	0.14%	228
2019 Q3	$949K	Sell	3,770 -128	-3%	-$41.7K	0.08%	182
2019 Q2	$1.55M	Buy	+3,898	New	+$1.57M	0.12%	115

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vident Investment Advisory's DTIL Position: Q2 2022 in Review

Vident Investment Advisory sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 593 shares — an estimated $55K sold.

Vident Investment Advisory first reported a position in DTIL in Q2 2019 and held it in 7 quarters. The position peaked at $2.21M in Q4 2019. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

Vident Investment Advisory reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
Vident Investment Advisory sold 593 Precision BioSciences shares in Q2 2022, an estimated $55K.
Vident Investment Advisory first reported a position in Precision BioSciences in Q2 2019 and held it in 7 quarters.
Vident Investment Advisory's Precision BioSciences position peaked at $2.21M in Q4 2019.
119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Vident Investment Advisory's 13F filing for Q2 2022, filed 15 Aug 2022.